NasdaqGM - Delayed Quote
USD
Axsome Therapeutics, Inc. (AXSM)
206.68
-1.67
(-0.80%)
At close: September 4 at 4:00:01 PM EDT
206.68
0.00
(0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade AXSM on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutAxsome Therapeutics is advancing its clinical pipeline with the initiation of the SUMMIT Phase 3 trial for AXS-05 in smoking cessation. The company reported Q2 revenue of $218.4 million, driven by strong sales from Auvelity, although it missed earnings estimates and recorded a net loss of $51.3 million.
